These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15694367)

  • 1. Hypertrophic effects of urocortin homologous peptides are mediated via activation of the Akt pathway.
    Chanalaris A; Lawrence KM; Townsend PA; Davidson S; Jamshidi Y; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
    Biochem Biophys Res Commun; 2005 Mar; 328(2):442-8. PubMed ID: 15694367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.
    Chanalaris A; Lawrence KM; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
    J Mol Cell Cardiol; 2003 Oct; 35(10):1295-305. PubMed ID: 14519439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death.
    Brar BK; Stephanou A; Knight R; Latchman DS
    J Mol Cell Cardiol; 2002 Apr; 34(4):483-92. PubMed ID: 11991736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
    Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
    J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes.
    Ikeda K; Tojo K; Otsubo C; Udagawa T; Hosoya T; Tajima N; Nakao K; Kawamura M
    Peptides; 2005 Dec; 26(12):2473-81. PubMed ID: 16005543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway.
    Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Tetich M; Kubera M; Leśkiewicz M; Lasoń W
    Neuropharmacology; 2005 Aug; 49(2):156-64. PubMed ID: 15996564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
    Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
    Heart Vessels; 2012 Mar; 27(2):202-7. PubMed ID: 21505854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF stimulates mesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner: involvement of c-fos and p27Kip1.
    Mahimainathan L; Ghosh-Choudhury N; Venkatesan BA; Danda RS; Choudhury GG
    Am J Physiol Renal Physiol; 2005 Jul; 289(1):F72-82. PubMed ID: 15701816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection mediated by urocortin is dependent on PKCepsilon activation.
    Lawrence KM; Kabir AM; Bellahcene M; Davidson S; Cao XB; McCormick J; Mesquita RA; Carroll CJ; Chanalaris A; Townsend PA; Hubank M; Stephanou A; Knight RA; Marber MS; Latchman DS
    FASEB J; 2005 May; 19(7):831-3. PubMed ID: 15764590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Okumura H; Nagaya N; Itoh T; Okano I; Hino J; Mori K; Tsukamoto Y; Ishibashi-Ueda H; Miwa S; Tambara K; Toyokuni S; Yutani C; Kangawa K
    Circulation; 2004 Jan; 109(2):242-8. PubMed ID: 14691041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes.
    Morisco C; Condorelli G; Trimarco V; Bellis A; Marrone C; Condorelli G; Sadoshima J; Trimarco B
    Circ Res; 2005 Feb; 96(2):180-8. PubMed ID: 15591229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes.
    Smani T; Calderón-Sanchez E; Gómez-Hurtado N; Fernández-Velasco M; Cachofeiro V; Lahera V; Ordoñez A; Delgado C
    Cardiovasc Res; 2010 Aug; 87(3):459-66. PubMed ID: 20189952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
    Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes.
    Railson JE; Liao Z; Brar BK; Buddle JC; Pennica D; Stephanou A; Latchman DS
    Cytokine; 2002 Mar; 17(5):243-53. PubMed ID: 12027405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.
    Condorelli G; Drusco A; Stassi G; Bellacosa A; Roncarati R; Iaccarino G; Russo MA; Gu Y; Dalton N; Chung C; Latronico MV; Napoli C; Sadoshima J; Croce CM; Ross J
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12333-8. PubMed ID: 12237475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cell size and contractile function by AKT in cardiomyocytes.
    Latronico MV; Costinean S; Lavitrano ML; Peschle C; Condorelli G
    Ann N Y Acad Sci; 2004 May; 1015():250-60. PubMed ID: 15201165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic receptor-mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a phosphatidylinositol 3-kinase dependent pathway refractory to the antiproliferative action of cyclic AMP.
    Colombo F; Gosselin H; El-Helou V; Calderone A
    J Cell Physiol; 2003 May; 195(2):322-30. PubMed ID: 12652658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.